Remove COPD Remove Outcomes Remove Ultrasounds
article thumbnail

Ultrasound in Cardiac Arrest

Mount Sinai EM

Ultrasound during cardiac arrest has quickly become standard. Initially, data suggested that the use of ultrasound during arrest increased pauses between compressions which worsens outcomes. The ideal view depends on the patient’s comorbid conditions such as COPD, obesity, cachexia, etc.

article thumbnail

Serial PoCUS for ED Patients with Acute Dyspnea: Is More Actually Better?

RebelEM

Background: Point-of-care ultrasound (PoCUS) is a valuable clinical tool in the assessment of acute dyspnea. Impact of serial cardiopulmonary point-of-care ultrasound exams in patients with acute dyspnoea: a randomized, controlled trial. PoCUS evaluations included lung ultrasound (LUS) and focused cardiac ultrasound (FoCUS).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A 40-something woman with acute pulmonary edema -- see the Speckle Tracking echocardiogram.

Dr. Smith's ECG Blog

A 49 year old woman with h/o COPD only presented with sudden dyspnea. On arrival, lung ultrasound confirmed pulmonary edema (B lines). Outcome : She was diagnosed with stress cardiomyopathy, though it is not entirely classic. She had acute pulmonary edema on exam. This is proximal LAD Occlusion until proven otherwise.

EKG/ECG 52
article thumbnail

Diagnostics and Therapeutics: Managing Pneumothorax

Taming the SRU

It can be further divided into two types: primary--those that occur in generally healthy individuals without underlying lung disease, and secondary--those that occur in individuals with underlying lung disease such as COPD [1]. The "lung point": an ultrasound sign specific to pneumothorax. Published 2020 Jul 23. doi:10.1002/14651858.CD013031.pub2

article thumbnail

Grand Rounds Recap 3.8.23

Taming the SRU

mepivacaine (1-3 h) 1% lidocaine +/- epi (2-3h) 0.25% bupivacaine (2-3 h) 0.25-0.5% mepivacaine (1-3 h) 1% lidocaine +/- epi (2-3h) 0.25% bupivacaine (2-3 h) 0.25-0.5% mg/kg IV Versed: 0.2 mg/kg IM, 0.2 mg/kg IN (may repeat to max of 0.4 mg/kg IN), 0.2

article thumbnail

A Comprehensive Guide to Surgical Clerking

Mind The Bleep

Ensure you management plan includes how you plan to rule out any immediate concerns and what the outcome is likely to be if normal. Your trust will have guidelines on the treatment regimen using chlordiazepoxide/lorazepam and pabrinex. You should also document what the likely action is if investigations/imaging come back negative.

article thumbnail

Evaluating Chronic Obstructive Pulmonary Disease

ACEP Now

Chronic obstructive pulmonary disease (COPD) is a chronic disease of the lungs caused by inflammatory and structural changes of the small airways and parenchyma of the lungs that result in chronic airflow obstruction and gas trapping. In 2019, the global prevalence of COPD was estimated to be 10.3 Click to enlarge.

COPD 52